Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMES and ABX for Recurrent High-Grade Glioma
NCT06330337Phase 3Recruiting
- Sponsor
- Third Affiliated Hospital of Zhejiang Chinese Medical University
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nab-paclitaxel in glioma, sponsored by Third Affiliated Hospital of Zhejiang Chinese Medical University. Started Apr 2024; status: recruiting.
02
Drugs
nab-paclitaxel
03
Conditions
glioma
Beyond the preview
Go deeper on NCT06330337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06330337.